Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

OBJECTIVE: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis. DESIGN: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically c...

Descripción completa

Detalles Bibliográficos
Autores principales: Münch, Andreas, Bohr, Johan, Miehlke, Stephan, Benoni, Cecilia, Olesen, Martin, Öst, Åke, Strandberg, Lars, Hellström, Per M, Hertervig, Erik, Armerding, Peter, Stehlik, Jiri, Lindberg, Greger, Björk, Jan, Lapidus, Annika, Löfberg, Robert, Bonderup, Ole, Avnström, Sören, Rössle, Martin, Dilger, Karin, Mueller, Ralph, Greinwald, Roland, Tysk, Curt, Ström, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717436/
https://www.ncbi.nlm.nih.gov/pubmed/25425655
http://dx.doi.org/10.1136/gutjnl-2014-308363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717436/
https://www.ncbi.nlm.nih.gov/pubmed/25425655
http://dx.doi.org/10.1136/gutjnl-2014-308363

Ejemplares similares